{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:32:29Z","timestamp":1793039549884,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341230"],"award-info":[{"award-number":["82341230"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404735"],"award-info":[{"award-number":["82404735"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.drup.2025.101344","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T16:55:07Z","timestamp":1765904107000},"page":"101344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["DEAF1 confers resistance to adriamycin-induced apoptosis and pyroptosis in multiple myeloma"],"prefix":"10.1016","volume":"85","author":[{"given":"Zhendong","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5500-7790","authenticated-orcid":false,"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanliang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwen","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0228-5102","authenticated-orcid":false,"given":"Ye","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drup.2025.101344_bib1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41408-023-00852-4","article-title":"Conditional survival in multiple myeloma and impact of prognostic factors over time","volume":"13","author":"Abdallah","year":"2023","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.drup.2025.101344_bib2","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/s41423-020-00630-3","article-title":"Necroptosis, pyroptosis and apoptosis: an intricate game of cell death","volume":"18","author":"Bertheloot","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.drup.2025.101344_bib3","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/s41467-024-46594-0","article-title":"The bone ecosystem facilitates multiple myeloma relapse and the evolution of heterogeneous drug resistant disease","volume":"15","author":"Bishop","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101344_bib4","first-page":"5969","article-title":"DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA","volume":"49","author":"Bodley","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2025.101344_bib5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ccell.2024.05.026","article-title":"IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma","volume":"42","author":"Bolomsky","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.drup.2025.101344_bib6","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1158\/0008-5472.CAN-22-3481","article-title":"Histone Methyltransferase NSD2 Activates PKCalpha to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma","volume":"83","author":"Chong","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2025.101344_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","article-title":"Regulated cell death pathways in doxorubicin-induced cardiotoxicity","volume":"12","author":"Christidi","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.drup.2025.101344_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039218","article-title":"Contribution of DEAF1 structural domains to the interaction with the breast cancer oncogene LMO4","volume":"7","author":"Cubeddu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.drup.2025.101344_bib9","article-title":"PNPO-Mediated Oxidation of DVL3 Promotes Multiple Myeloma Malignancy and Osteoclastogenesis by Activating the Wnt\/beta-Catenin Pathway","volume":"12","author":"Deng","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.drup.2025.101344_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41571-025-01041-x","article-title":"EHA-EMN Evidence-Based Guidelines for diagnosis, treatment and follow-up of patients with multiple myeloma","author":"Dimopoulos","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.drup.2025.101344_bib11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1182\/blood.2024025987","article-title":"Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myeloma","volume":"145","author":"Eckmann","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101344_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17060982","article-title":"Genetic Insights into Breast Cancer in Northeastern Mexico: Unveiling Gene-Environment Interactions and Their Links to Obesity and Metabolic Diseases","volume":"17","author":"Gallardo-Blanco","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drup.2025.101344_bib13","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1080\/15548627.2024.2374693","article-title":"FOXO-regulated DEAF1 controls muscle regeneration through autophagy","volume":"20","author":"Goh","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.drup.2025.101344_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bneo.2025.100100","article-title":"Ambroxol induces myeloma cell death by inhibiting autophagy","volume":"2","author":"Hattori","year":"2025","journal-title":"Blood Neoplasia"},{"key":"10.1016\/j.drup.2025.101344_bib15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41573-021-00199-0","article-title":"Advances in targeting 'undruggable' transcription factors with small molecules","volume":"20","author":"Henley","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drup.2025.101344_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/bgaf032","article-title":"Integrated functional genomics-identified DEAF1 in oxidative stress and hepatocellular carcinoma development","volume":"46","author":"Huang","year":"2025","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.drup.2025.101344_bib17","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1182\/blood.2024024590","article-title":"Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma","volume":"144","author":"John","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101344_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112678","article-title":"Multiple Myeloma Inhibitory Activity of Plant Natural Products","volume":"13","author":"Johrer","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.drup.2025.101344_bib19","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1476-5381.2011.01449.x","article-title":"Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-kappaB and STAT3 regulated gene products in multiple myeloma cells","volume":"164","author":"Kannaiyan","year":"2011","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.drup.2025.101344_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040659","article-title":"Doxorubicin-An Agent with Multiple Mechanisms of Anticancer Activity","volume":"12","author":"Kciuk","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.drup.2025.101344_bib21","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41591-022-02178-3","article-title":"Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma","volume":"29","author":"Larrayoz","year":"2023","journal-title":"Nat. Med"},{"key":"10.1016\/j.drup.2025.101344_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1182\/blood.2023020276","article-title":"Integrated epigenetic and transcriptional single-cell analysis of t(11;14) multiple myeloma and its BCL2 dependency","volume":"143","author":"Leblay","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101344_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101065","article-title":"ABCB1-dependent collateral sensitivity of multidrug-resistant colorectal cancer cells to the survivin inhibitor MX106\u20134\u2009C","volume":"73","author":"Lei","year":"2024","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.drup.2025.101344_bib24","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2147\/IJN.S427783","article-title":"Efficient Sequential Co-Delivery Nanosystem for Inhibition of Tumor and Tumor-Associated Fibroblast-Induced Resistance and Metastasis","volume":"19","author":"Li","year":"2024","journal-title":"Int J. Nanomed."},{"key":"10.1016\/j.drup.2025.101344_bib25","article-title":"Cycloruthenated Self-Assembly with Metabolic Inhibition to Efficiently Overcome Multidrug Resistance in Cancers","volume":"34","author":"Li","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.drup.2025.101344_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00011-024-01983-5","article-title":"The role of celastrol in inflammation and diseases","volume":"74","author":"Lei","year":"2025","journal-title":"Inflamm Res"},{"key":"10.1016\/j.drup.2025.101344_bib27","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s13238-019-0618-z","article-title":"PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation","volume":"10","author":"Li","year":"2019","journal-title":"Protein Cell"},{"key":"10.1016\/j.drup.2025.101344_bib28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2021.08.030","article-title":"Celastrol in cancer therapy: Recent developments, challenges and prospects","volume":"521","author":"Lim","year":"2021","journal-title":"Cancer Lett"},{"key":"10.1016\/j.drup.2025.101344_bib29","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1158\/1078-0432.CCR-18-3510","article-title":"CKLF1 Enhances Inflammation-Mediated Carcinogenesis and Prevents Doxorubicin-Induced Apoptosis via IL6\/STAT3 Signaling in HCC","volume":"25","author":"Liu","year":"2019","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.drup.2025.101344_bib30","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/jnci\/djae321","article-title":"The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045","volume":"117","author":"Mafra","year":"2025","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.drup.2025.101344_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108839","article-title":"Pathophysiological roles of autophagy and aldo-keto reductases in development of doxorubicin resistance in gastrointestinal cancer cells","volume":"314","author":"Matsunaga","year":"2019","journal-title":"Chem. Biol. Inter."},{"key":"10.1016\/j.drup.2025.101344_bib32","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/hmg\/ddac200","article-title":"Expansion and mechanistic insights into de novo DEAF1 variants in DEAF1-associated neurodevelopmental disorders","volume":"32","author":"McGee","year":"2023","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.drup.2025.101344_bib33","first-page":"2238","article-title":"YY1-mediated reticulocalbin-2 upregulation promotes the hepatocellular carcinoma progression via activating MYC signaling","volume":"11","author":"Mei","year":"2021","journal-title":"Am. J. Cancer Res"},{"key":"10.1016\/j.drup.2025.101344_bib34","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S1470-2045(20)30756-7","article-title":"Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group","volume":"22","author":"Moreau","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.drup.2025.101344_bib35","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1038\/s41436-019-0473-6","article-title":"De novo and biallelic DEAF1 variants cause a phenotypic spectrum","volume":"21","author":"Nabais Sa","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.drup.2025.101344_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020146","article-title":"Syntaxin 1A Gene Is Negatively Regulated in a Cell\/Tissue Specific Manner by YY1 Transcription Factor, Which Binds to the -183 to -137 Promoter Region Together with Gene Silencing Factors Including Histone Deacetylase","volume":"11","author":"Nakayama","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.drup.2025.101344_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139186","article-title":"Antisense oligonucleotides-based approaches for the treatment of multiple myeloma","volume":"291","author":"Oprea","year":"2025","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.drup.2025.101344_bib38","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1182\/blood.2023019758","article-title":"Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis","volume":"142","author":"Poos","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101344_bib39","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1158\/0008-5472.CAN-24-1440","article-title":"Selective Enhancer Gain-of-Function Deregulates MYC Expression in Multiple Myeloma","volume":"84","author":"Rahmat","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.drup.2025.101344_bib40","first-page":"313","article-title":"Single-cell profiling in multiple myeloma: insights, problems, and promises","volume":"142","author":"Samur","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101344_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103035","article-title":"DNAJC12 causes breast cancer chemotherapy resistance by repressing doxorubicin-induced ferroptosis and apoptosis via activation of AKT","volume":"70","author":"Shen","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.drup.2025.101344_bib42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem Sci."},{"key":"10.1016\/j.drup.2025.101344_bib43","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.3390\/ijms16011406","article-title":"Structure and function of SET and MYND domain-containing proteins","volume":"16","author":"Spellmon","year":"2015","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.drup.2025.101344_bib44","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.1182\/blood-2008-09-179796","article-title":"Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kappaB with antimyeloma activity in vitro and in vivo","volume":"113","author":"Tiedemann","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101344_bib45","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1182\/blood-2005-10-009084","article-title":"ABCG2 expression, function, and promoter methylation in human multiple myeloma","volume":"108","author":"Turner","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.drup.2025.101344_bib46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.drup.2025.101344_bib47","article-title":"Disruption of Proteostasis by Natural Products and Synthetic Compounds That Induce Pervasive Unfolding of Proteins: Therapeutic Implications","volume":"16","author":"Vilaboa","year":"2023","journal-title":"Pharm. (Basel)"},{"key":"10.1016\/j.drup.2025.101344_bib48","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1038\/s41467-022-31430-0","article-title":"The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma","volume":"13","author":"Vo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drup.2025.101344_bib49","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1101\/gad.352186.124","article-title":"The MYC-MAF-SAGA axis drives oncogenic gene expression in multiple myeloma","volume":"38","author":"Wang","year":"2024","journal-title":"Genes Dev."},{"key":"10.1016\/j.drup.2025.101344_bib50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1074-7613(04)00030-5","article-title":"Transcriptional inactivation of STAT3 by PPARgamma suppresses IL-6-responsive multiple myeloma cells","volume":"20","author":"Wang","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.drup.2025.101344_bib51","doi-asserted-by":"crossref","first-page":"114882","DOI":"10.1016\/j.biopha.2023.114882","article-title":"Celastrol as an emerging anticancer agent: Current status, challenges and therapeutic strategies","volume":"163","author":"Wang","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drup.2025.101344_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101344_bib53","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ng.2583","article-title":"The CCND1c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma","volume":"45","author":"Weinhold","year":"2013","journal-title":"Nat. Genet"},{"key":"10.1016\/j.drup.2025.101344_bib54","article-title":"Inhibition of FOXM1 Synergizes with BH3 Mimetics Venetoclax and Sonrotoclax in Killing Multiple Myeloma Cells through Repressing MYC Pathway","author":"Wen","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.drup.2025.101344_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41594-025-01597-3","article-title":"The PURB-HOTAIR complex regulates p53-dependent promoter-specific transcriptional activation","author":"Xia","year":"2025","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.drup.2025.101344_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202470095","article-title":"A CTL-Inspired Killing System Using Ultralow-Dose Chemical-Drugs to Induce a Pyroptosis-Mediated Antitumor Immune Function","volume":"36","author":"Yin","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.drup.2025.101344_bib57","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1016\/j.apsb.2023.09.008","article-title":"TBC1D15 deficiency protects against doxorubicin cardiotoxicity via inhibiting DNA-PKcs cytosolic retention and DNA damage","volume":"13","author":"Yu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.drup.2025.101344_bib58","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","article-title":"A guide to cell death pathways","volume":"25","author":"Yuan","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.drup.2025.101344_bib59","doi-asserted-by":"crossref","first-page":"19331","DOI":"10.1038\/s41598-025-03132-2","article-title":"The 3D genome of plasma cells in multiple myeloma","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drup.2025.101344_bib60","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","article-title":"Gasdermin E suppresses tumour growth by activating anti-tumour immunity","volume":"579","author":"Zhang","year":"2020","journal-title":"Nature"}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625001475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625001475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T08:03:16Z","timestamp":1773907396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764625001475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":60,"alternative-id":["S1368764625001475"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2025.101344","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DEAF1 confers resistance to adriamycin-induced apoptosis and pyroptosis in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2025.101344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101344"}}